ARTICLE | Company News
Vical, Merck deal
June 13, 2005 7:00 AM UTC
MRK exercised options to license three VICL cancer vaccine targets. Under a 1997 deal that was amended in 2003, VICL granted MRK options to use its non-viral gene delivery technology for three of its ...